Ultragenyx Outlines 2027 Financial Targets and Operational Outlook
At the UBS Global Biopharma Conference, Ultragenyx management provided a financial outlook targeting full-year profitability in 2027 and outlined key budget constraints for R&D and SG&A expenses.